Full Breakdown
Health Canada Issues Recall of Amlodipine Due to Medication Mix-Up
2/9/2026, 8:37:31 PM
Core Event: Medication Recall Announcement
Health Canada has issued a recall for MAR-Amlodipine 5 mg tablets, a medication used to treat high blood pressure and chest pain, due to a mix-up that may have resulted in some bottles containing midodrine 2.5 mg tablets instead. This error poses significant health risks, as taking midodrine instead of amlodipine can lead to dangerously high blood pressure, dizziness, fainting, slow heartbeats, and potential organ damage.
Background & Context: The Risk of Medication Errors
The recall stems from a labeling error by Marcan Pharmaceuticals Inc., which has raised concerns about the safety protocols in place for medication distribution. Midodrine is typically prescribed for low blood pressure, and the consequences of patients inadvertently taking this medication instead of amlodipine could be severe, particularly for vulnerable populations such as children, who may face a higher risk of harm.
Key Figures & Groups: Health Canada and Marcan Pharmaceuticals Inc.
Health Canada is the federal department responsible for helping Canadians maintain and improve their health, while Marcan Pharmaceuticals Inc. is the manufacturer of the affected medication. Both entities are involved in addressing the implications of this recall and ensuring public safety.
Official Statements & Responses
Health Canada has emphasized the seriousness of the situation, advising consumers to check their medication bottles for the correct labeling. The agency has stated, “Taking midodrine instead of amlodipine could lead to serious health risks,” highlighting the urgent need for individuals to verify their prescriptions.
Criticism & Opposition: Concerns Over Safety Protocols
Critics have raised concerns regarding the safety protocols followed by Marcan Pharmaceuticals Inc. and the effectiveness of Health Canada's oversight in preventing such mix-ups. The incident has sparked discussions about the need for stricter regulations and more rigorous checks in the pharmaceutical industry to protect consumers from similar errors in the future.
Data & Statistics: Identifying the Affected Products
To help consumers identify the correct medication, Health Canada has provided specific details: the genuine MAR-Amlodipine tablets are white to off-white, have eight sides, and are marked with the numbers “210” and “5.” In contrast, the incorrectly packaged midodrine tablets are round and marked with “M2.” This clear distinction is crucial for preventing potential health risks.
What's Next: Ongoing Monitoring and Consumer Guidance
Health Canada continues to monitor the situation and has urged consumers who may have purchased the affected product to return it to their pharmacy. The agency is also expected to release further guidance on how to safely manage prescriptions in light of this incident.
Verbatim Quotes
“Taking midodrine instead of amlodipine could lead to serious health risks Subscribe now to read the latest news in your city and across Canada.” — Health Canada
This recall serves as a critical reminder of the importance of medication safety and the need for vigilance among consumers and healthcare providers alike.
